Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BLI-800 in Renal and Hepatic Impairment
NCT00583713Phase 2Completed
- Sponsor
- Braintree Laboratories
- Start
- Aug 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sodium sulfate + potassium sulfate + magnesium sulfate in bowel preparation (3 arms), sponsored by Braintree Laboratories. Primary endpoints: Maximum Observed Concentration at 1 day, Time to Maximum Concentration at 1 day and 3 more. Started Aug 2007; status: completed.
02
Drugs
sodium sulfate + potassium sulfate + magnesium sulfate
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT00583713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00583713.